Transatrial lead implantation using the 4-Fr lumenless pacing lead and delivery system in young adults with congenital heart disease.
We report the technique of transatrial delivery of the Medtronic 3830 SelectSecure lead (Medtronic Inc., Minneapolis, MN, USA) for right ventricular endocardial pacing in two young adults with congenital heart disease who had multiple pacing lead failures and superior vena cava occlusion. The deflectable catheter delivery system used to position the SelectSecure lead provided the opportunity to map the right ventricular endocardial surface and determine the best available pacing site. At midterm follow-up, both systems are functioning well.
Fishberger
Steven B
SB
Division of Pediatric Cardiology, Yale University School of Medicine, New Haven, Connecticut, USA. stevefishberger@hotmail.com
Rollinson
Nancy R
NR
Warsy
Irfan
I
Whang
Brian
B
Wang
Brian
B
Kim
Richard W
RW
D054537:Atrioventricular Block / Q000628:therapy; D002311:Cardiomyopathy, Dilated / Q000628:therapy; D005260:Female; D006330:Heart Defects, Congenital / Q000628:therapy*; D006345:Heart Septal Defects, Ventricular / Q000628:therapy; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial; D019919:Prosthesis Implantation / Q000379:methods; D055815:Young Adult